Génome Québec congratulates Patrice Allibert and the team at GenePOC, who received an investment of $10M from the Debiopharm Group. The funds will be used to accelerate the development of the technology and the world-wide launch of its portable diagnostics system developed in Québec and enabling rapid microbial testing in less than an hour at the point of care.

The system was developed by GenePOC, a company funded in 2007 by Dr. Michel C. Bergeron of the Infectious Disease Research Centre at Université Laval through several Canadian funding agencies, including Génome Québec. 

To read the press release, click here.

Photo credit: Le Soleil